RediNews
ETFs Holding AMGN »    AMGN Historical Stock Prices »
AMGN News Video: Wed, Dec 13, 2017, 12:53 PM — Daily Dividend Report: AMGN, BEN, WDFC, O, XRAY


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Amgen is a global biotechnology company that discovers, develops, manufactures and delivers human therapeutics. Co. focuses its research and development on human therapeutics for the treatment of illness in the areas of oncology/hematology, cardiovascular disease, inflammation, bone health, nephrology and neuroscience. Co.'s principal products include ENBREL, Neulasta®, Aranesp®, Prolia®, Sensipar®/Mimpara®, XGEVA®, EPOGEN®, and NEUPOGEN®. In addition, Co. markets several other products, including KYPROLIS® (carfilzomib), Vectibix® (panitumumab), Nplate® (romiplostim), Repatha® (evolocumab), BLINCYTO® (blinatumomab), IMLYGIC® (talimogene laherparepvec) and Corlanor® (ivabradine). Self directed investors in Amgen Inc will be interested in keeping up with all Amgen Inc news they can find, both AMGN news originating from the company in the form of press releases, as well as seeing how independent media outlets are reporting news on AMGN. At RediNews, we simplify this task by presenting both AMGN news releases originating from Amgen Inc itself, and AMGN news from a variety of media outlets. Visitors can browse this news online and through our AMGN RSS news feed.

AMGN News

AMGN News — Articles, Videos, & Press Releases

Notable Monday Option Activity: HOG, TWX, AMGN
17 hours, 58 minutes ago — Stock Options Channel
Noteworthy ETF Outflows: IWB, AMGN, GILD, ABT
18 hours, 3 minutes ago — ETF Channel
Healthcare ETFs to Watch As Q4 Earnings Unfold
21 hours, 6 minutes ago — Zacks
Amgen/Allergan's Avastin Biosimilar Secures EU Approval
Friday, January 19, 2018, 9:34 AM — Zacks
Cancer Space Update: Label Expansions, Data Readouts in Focus
Friday, January 19, 2018, 9:23 AM — Zacks
Spectrum Pharmaceuticals Up 134% in 6 Months: Here's Why
Friday, January 19, 2018, 9:06 AM — Zacks
Here's Why Nektar Stock Skyrocketed Almost 500% in a Year
Friday, January 19, 2018, 9:00 AM — Zacks
Can These 4 Large-Cap Drug Stocks Deliver an Encore in '18?
Thursday, January 18, 2018, 3:26 PM — Zacks
Amgen Gets FDA Nod to Add ENDEAVOR Data on Kyprolis Label
Thursday, January 18, 2018, 11:45 AM — Zacks
Amgen Takes Over #40 Spot From NVIDIA
Tuesday, January 16, 2018, 4:39 PM — Market News Video
Will Amgen (AMGN) Continue to Tread Growth Path This Year?
Tuesday, January 16, 2018, 8:55 AM — Zacks
4 ETFs Set to Surge in Q4 Earnings
Monday, January 15, 2018, 9:57 AM — Zacks
XLV, MRK, AMGN, GILD: ETF Outflow Alert
Friday, January 12, 2018, 10:53 AM — ETF Channel
Can Biotech Keep Last Year's Momentum Alive in 2018?
Thursday, January 11, 2018, 9:19 AM — Zacks
AstraZeneca's Asthma Drug Benralizumab Gets Approval in EU
Thursday, January 11, 2018, 8:01 AM — Zacks
Notable Wednesday Option Activity: MLM, WTW, AMGN
Wednesday, January 10, 2018, 3:21 PM — Stock Options Channel
June 2019 Options Now Available For Amgen (AMGN)
Wednesday, January 10, 2018, 10:40 AM — Stock Options Channel
Novartis Starts Trial on Psoriasis Drug Cosentyx Biosoimilar
Wednesday, January 10, 2018, 8:36 AM — Zacks
Merck's Keytruda Combo Gets Breakthrough Therapy Status
Wednesday, January 10, 2018, 7:55 AM — Zacks
Amgen Announces Acceptance of MAA for Evenity in Europe
Tuesday, January 9, 2018, 9:42 AM — Zacks
Merck's (MRK) Keytruda Succeeds in High-Risk Melanoma Study
Tuesday, January 9, 2018, 9:38 AM — Zacks
FDA Approvals Surge in 2017: Here's a Look at the Numbers
Tuesday, January 9, 2018, 6:27 AM — Zacks
Amgen's (AMGN) Xgeva Gets FDA Approval for Multiple Myeloma
Monday, January 8, 2018, 2:42 PM — Zacks
Amgen a Top 25 Dividend Giant With 2.93% Yield (AMGN)
Monday, January 8, 2018, 8:05 AM — ETF Channel
ImmunoGen Starts Phase I Study on Leukemia Candidate IMGN632
Friday, January 5, 2018, 12:41 PM — Zacks
Key Biosimilar Approvals in 2017: Progress Report
Friday, January 5, 2018, 7:26 AM — Zacks
3 Large-Cap Pharma Stocks to Watch Out for This New Year
Thursday, January 4, 2018, 5:28 PM — Zacks
XLV, AMGN, GILD, LLY: Large Outflows Detected at ETF
Thursday, January 4, 2018, 11:13 AM — ETF Channel
Can AbbVie (ABBV) Stock Keep the Momentum Alive in 2018?
Thursday, January 4, 2018, 9:33 AM — Zacks
Noteworthy Wednesday Option Activity: GM, AMGN, PYPL
Wednesday, January 3, 2018, 1:25 PM — Stock Options Channel
iShares Russell 1000 Value ETF Experiences Big Inflow
Wednesday, December 27, 2017, 11:12 AM — ETF Channel
Build a Christmas Tree with Top-Ranked Stocks
Friday, December 22, 2017, 9:13 AM — Zacks
Why is Nektar (NKTR) Stock Up More Than 350% This Year?
Friday, December 22, 2017, 7:30 AM — Zacks
GOP Passes Landmark Tax Bill: Best & Worst for Stocks
Thursday, December 21, 2017, 9:41 AM — Zacks
Radius Health to Get Third Day-180 List of Outstanding Issues
Monday, December 18, 2017, 4:45 PM — Zacks
Spectrum Pharma Dismisses CEO, Makes Leadership Changes
Monday, December 18, 2017, 8:37 AM — Zacks
Merck's Keytruda Misses Primary End Point for Gastric Cancer
Friday, December 15, 2017, 1:40 PM — Zacks
Pfizer's Arthritis Drug Gets FDA Nod for Label Expansion
Friday, December 15, 2017, 1:37 PM — Zacks
Notable ETF Inflow Detected - IWD, MDT, ABT, AMGN
Friday, December 15, 2017, 11:00 AM — ETF Channel
AMGN Dividend Yield Pushes Past 3%
Thursday, December 14, 2017, 3:13 PM — Dividend Channel
Roche/AbbVie Report Positive Phase III Results on Venclexta
Wednesday, December 13, 2017, 6:15 AM — Zacks
Roche Reports Positive Data from Tecentriq Combination Study
Monday, December 11, 2017, 5:11 PM — Zacks
3 Stocks in Focus as Biotech M&A Hopes for 2018 Rise
Monday, December 11, 2017, 8:40 AM — Zacks
Sanofi Begins Combo Studies on Multiple Myeloma Candidate
Friday, December 8, 2017, 8:29 AM — Zacks
IWD, PM, MDT, AMGN: Large Inflows Detected at ETF
Thursday, December 7, 2017, 11:08 AM — ETF Channel
Roche's Avastin Gets Full FDA Approval for Brain Cancer
Wednesday, December 6, 2017, 2:08 PM — Zacks
AbbVie/J&J's Imbruvica Succeeds in Combo Study with Rituxan
Wednesday, December 6, 2017, 7:52 AM — Zacks
AbbVie Psoriasis Candidate Succeeds in 4th Phase III Study
Tuesday, December 5, 2017, 8:52 AM — Zacks
Mylan Up on FDA Approval & Amazon's Rumored Pharmacy Interest
Monday, December 4, 2017, 8:46 AM — Zacks
Amgen's PCSK9 Inhibitor Gets FDA Nod for Stroke Prevention
Monday, December 4, 2017, 7:10 AM — Zacks
Noteworthy Thursday Option Activity: HCA, AMGN, FFIV
Thursday, November 30, 2017, 1:26 PM — Stock Options Channel
AbbVie Stock Up More Than 30% So Far in 2H17: Here's Why
Thursday, November 30, 2017, 9:17 AM — Zacks
5 Biotech and Pharma Stocks with FDA Catalysts this December
Thursday, November 30, 2017, 7:18 AM — Zacks
Bullish Two Hundred Day Moving Average Cross - AMGN
Wednesday, November 29, 2017, 11:05 AM — Dividend Channel
iShares Russell 1000 Value ETF Experiences Big Inflow
Wednesday, November 29, 2017, 10:49 AM — ETF Channel
Nektar (NKTR) Stock Up More than 300% This Year: Here's Why
Friday, November 24, 2017, 1:39 PM — Zacks
Interesting AMGN Put And Call Options For July 2018
Wednesday, November 22, 2017, 10:39 AM — Stock Options Channel
J&J Seeks Darzalex's Label Expansion in First-Line Setting
Wednesday, November 22, 2017, 9:29 AM — Zacks
Amgen (AMGN) Unveils Auto Injector Device for Enbrel in US
Monday, November 20, 2017, 8:30 AM — Zacks
Noteworthy ETF Inflows: DGRO, MRK, WMT, AMGN
Friday, November 17, 2017, 10:48 AM — ETF Channel
Biotechs Trading Lower in Q4 on Macro Uncertainty, Tepid Q3
Friday, November 17, 2017, 6:09 AM — Zacks
AstraZeneca's (AZN) Asthma Drug Benralizumab Approved by FDA
Wednesday, November 15, 2017, 8:47 AM — Zacks
Sum Up The Parts: XLV Could Be Worth $90
Wednesday, November 15, 2017, 8:22 AM — ETF Channel
Amgen is Oversold
Tuesday, November 14, 2017, 11:31 AM — Dividend Channel
Ex-Dividend Reminder: U.S. Physical Therapy, Allergan and Amgen
Tuesday, November 14, 2017, 9:59 AM — Dividend Channel
Novartis (NVS) Arm's Biosimilars Study Results Encourage
Tuesday, November 14, 2017, 7:31 AM — Zacks
Amgen Gets Positive CHMP Opinion to Expand Nplate's Label
Monday, November 13, 2017, 7:57 AM — Zacks
Ligand (LGND) Q3 Earnings & Revenues Top, 2017 View Raised
Friday, November 10, 2017, 9:52 AM — Zacks
XLV, MRK, ABBV, AMGN: ETF Outflow Alert
Thursday, November 9, 2017, 11:10 AM — ETF Channel
Radius Health (RDUS) Earnings Miss in Q3, Tymlos in Focus
Friday, November 3, 2017, 7:21 AM — Zacks
IWD, MRK, WMT, AMGN: ETF Inflow Alert
Wednesday, November 1, 2017, 11:05 AM — ETF Channel
Pfizer (PFE) Beats on Q3 Earnings, Raises 2017 EPS View
Tuesday, October 31, 2017, 9:53 AM — Zacks
3 ETFs to Watch on Biotech Earnings
Sunday, October 29, 2017, 1:04 PM — Zacks
AbbVie (ABBV) Q3 Earnings Top, Revenues In Line, View Up
Friday, October 27, 2017, 10:15 AM — Zacks
BioMarin (BMRN) Q3 Loss Narrows, Profit Guidance Raised
Friday, October 27, 2017, 9:30 AM — Zacks
Will Radius Health (RDUS) Disappoint This Earnings Season?
Friday, October 27, 2017, 8:02 AM — Zacks
Amgen (AMGN) Q3 Earnings Top, Sales Decline Y/Y, Stock Falls
Thursday, October 26, 2017, 9:21 AM — Zacks
Key Predictions for Q3 Earnings Reports of ABBV, MRK
Thursday, October 26, 2017, 8:06 AM — Zacks
Notable Wednesday Option Activity: AMGN, LUV, TRIP
Wednesday, October 25, 2017, 1:57 PM — Stock Options Channel
IWD, MRK, WMT, AMGN: ETF Inflow Alert
Tuesday, October 24, 2017, 11:03 AM — ETF Channel
Biogen (BIIB) Tops Q3 Earnings & Sales, Spinraza Sales Up
Tuesday, October 24, 2017, 10:53 AM — Zacks
Drug/Biotech Stocks Q3 Earnings on Oct 25: AMGN, GSK, VRTX
Tuesday, October 24, 2017, 7:12 AM — Zacks
What's in the Cards for Amgen (AMGN) this Earnings Season?
Friday, October 20, 2017, 8:50 AM — Zacks
Teva Submits BLA to FDA for Migraine Candidate Fremanezumab
Thursday, October 19, 2017, 7:20 AM — Zacks
What's in the Cards for Novartis (NVS) This Earnings Season?
Wednesday, October 18, 2017, 4:36 AM — Zacks
ImmunoGen to Push Leukemia Candidate into Phase I Trial
Tuesday, October 17, 2017, 3:55 PM — Zacks
Noteworthy Tuesday Option Activity: PF, QCOM, AMGN
Tuesday, October 17, 2017, 3:23 PM — Stock Options Channel
Zacks Industry Outlook Highlights: Gilead, Teva, Pfizer and Amgen
Tuesday, October 17, 2017, 7:44 AM — Zacks
Pharma Industry Outlook - October 2017
Monday, October 16, 2017, 1:59 PM — Zacks
Noteworthy ETF Inflows: IWD, WMT, AMGN, SLB
Monday, October 16, 2017, 11:01 AM — ETF Channel
Mylan Gets Complete Response Letter For Biosimilar Neulasta
Wednesday, October 11, 2017, 7:30 AM — Zacks
Amgen Label Expansion Application for Prolia Accepted by FDA
Tuesday, October 10, 2017, 9:00 AM — Zacks
Forget Teva (TEVA), Buy These 5 Drug Stocks Instead
Monday, October 9, 2017, 8:20 AM — Zacks
Cancer Space Last Week Update: Pipeline Expansion in Focus
Monday, October 9, 2017, 8:13 AM — Zacks
Notable ETF Inflow Detected - IWD, MRK, WMT, AMGN
Friday, October 6, 2017, 11:08 AM — ETF Channel
Regeneron and Sanofi Get Favorable Ruling Against Amgen
Friday, October 6, 2017, 7:00 AM — Zacks
AbbVie (ABBV) Stock Up Almost 17% in One Month: Here's Why
Thursday, October 5, 2017, 8:32 AM — Zacks
Amgen Enters Into an Immuno-Oncology Partnership With CytomX
Wednesday, October 4, 2017, 7:11 AM — Zacks
Notable Tuesday Option Activity: AMGN, AMD, PAYX
Tuesday, October 3, 2017, 3:40 PM — Stock Options Channel
3 Top-Ranked Big Biotech Stocks to Buy Now
Tuesday, October 3, 2017, 7:30 AM — Zacks
Radius (RDUS) Enrols First Patient in Breast Cancer Study
Monday, October 2, 2017, 7:50 AM — Zacks
Amgen Takes Over #38 Spot From International Business Machines Corp
Friday, September 29, 2017, 4:36 PM — Market News Video
How Will Trump's Proposed Tax Reform Impact Drug Companies?
Friday, September 29, 2017, 7:28 AM — Zacks
Ligand's Captisol Deals Set to Drive Growth in the Long Run
Friday, September 29, 2017, 7:25 AM — Zacks
Allergan (AGN) Pipeline & New Drugs to Counter Generic Woes
Friday, September 29, 2017, 7:20 AM — Zacks
Sanofi Rides on Genzyme & Vaccines Unit, Diabetes Sales Weak
Thursday, September 28, 2017, 7:23 AM — Zacks
Noteworthy ETF Inflows: FVD, BMS, AMGN, CMI
Wednesday, September 27, 2017, 10:50 AM — ETF Channel
Merck's Keytruda Gets FDA Nod for Advanced Gastric Cancer
Monday, September 25, 2017, 8:40 AM — Zacks
Noteworthy Thursday Option Activity: AMGN, FFIV, EBIX
Thursday, September 21, 2017, 3:23 PM — Stock Options Channel
4 Sell-Ranked Biotech Stocks with Falling Estimates to Avoid
Thursday, September 21, 2017, 12:58 PM — Zacks
Pfizer Sues J&J, Accuses it of Preventing Inflectra Uptake
Thursday, September 21, 2017, 8:25 AM — Zacks
Novartis Poised to Grow on Oncology Portfolio & Biosimilars
Wednesday, September 20, 2017, 12:32 PM — Zacks
iShares Russell 1000 Value ETF Experiences Big Inflow
Tuesday, September 19, 2017, 11:33 AM — ETF Channel
Is Amgen (AMGN) a Great Stock for Value Investors?
Tuesday, September 19, 2017, 7:40 AM — Zacks
Novartis Announces Positive Data on Urticaria Drug Xolair
Monday, September 18, 2017, 4:03 PM — Zacks
Amgen/Allergan's Avastin Biosimilar Secures FDA Approval
Friday, September 15, 2017, 8:33 AM — Zacks
Biosimilar 2017 Progress Report: Stocks in Focus
Thursday, September 14, 2017, 3:01 PM — Zacks
Noteworthy Thursday Option Activity: AMGN, RCL, CVX
Thursday, September 14, 2017, 2:22 PM — Stock Options Channel
Idexx Laboratories Becomes #44 Most Shorted Nasdaq 100 Component, Replacing Amgen
Wednesday, September 13, 2017, 2:32 PM — Market News Video
Amgen Reaches Analyst Target Price
Wednesday, September 13, 2017, 9:40 AM — ETF Channel
Novartis' BLA for Biosimilar of Rituxan Accepted by the FDA
Tuesday, September 12, 2017, 9:27 AM — Zacks
AbbVie's RA Candidate Meets Primary Endpoint in Phase III
Tuesday, September 12, 2017, 8:59 AM — Zacks
Interesting AMGN Put And Call Options For January 2020
Monday, September 11, 2017, 11:26 AM — Stock Options Channel
TQQQ, AMGN, KHC, PCLN: ETF Outflow Alert
Monday, September 11, 2017, 11:24 AM — ETF Channel
Noteworthy Thursday Option Activity: AMGN, CVX, CMCSA
Thursday, September 7, 2017, 1:57 PM — Stock Options Channel
Amgen/AstraZeneca Asthma Candidate Tezepelumab Shows Promise
Thursday, September 7, 2017, 9:06 AM — Zacks
AstraZeneca's COPD Candidate Duaklir Reports Positive Data
Thursday, September 7, 2017, 8:18 AM — Zacks
Merck's (MRK) Keytruda Gets EU Approval for Bladder Cancer
Wednesday, September 6, 2017, 9:05 AM — Zacks
Ligand (LGND) Diabetes Candidate Positive in Phase II Study
Wednesday, September 6, 2017, 8:03 AM — Zacks
Key FDA Regulatory Events to Watch Out for in Sep 2017
Monday, September 4, 2017, 6:05 AM — Zacks
Noteworthy ETF Outflows: TQQQ, AMGN, KHC, PCLN
Friday, September 1, 2017, 10:54 AM — ETF Channel
Amgen Gets EU Nod to Expand Hyperparathyroidism Drug Label
Friday, September 1, 2017, 9:11 AM — Zacks
Immunogen Inks Deal With Jazz Pharma to Develop ADC Molecule
Wednesday, August 30, 2017, 9:47 AM — Zacks
Amgen Presents New Repatha Analysis from FOURIER Study
Tuesday, August 29, 2017, 9:30 AM — Zacks
Biogen's Humira Biosimilar Imraldi Gets Approval in EU
Friday, August 25, 2017, 9:13 AM — Zacks
Amgen (AMGN) Down 6.4% Since Earnings Report: Can It Rebound?
Friday, August 25, 2017, 1:56 AM — Zacks
ProShares UltraPro QQQ Experiences Big Inflow
Thursday, August 24, 2017, 10:53 AM — ETF Channel
Can Sanofi (SNY) Sustain the Solid 1H Momentum in 2H17?
Thursday, August 24, 2017, 9:53 AM — Zacks
4 Biotech Stocks to Add to your Portfolio Post Q2 Earnings
Tuesday, August 22, 2017, 8:10 AM — Zacks
Add Up The Parts: PWV Could Be Worth $39
Friday, August 18, 2017, 8:53 AM — ETF Channel
Noteworthy ETF Inflows: TQQQ, GOOG, AMGN, BIIB
Wednesday, August 16, 2017, 10:45 AM — ETF Channel
Can Ligand's Captisol Deals Boost Growth in the Long Run?
Tuesday, August 15, 2017, 8:09 AM — Zacks
Are Amgen's New Drugs Doing Well Enough to Drive Sales?
Tuesday, August 15, 2017, 7:05 AM — Zacks
Ex-Dividend Reminder: Thomson Reuters, Amgen and ResMed
Friday, August 11, 2017, 10:19 AM — Dividend Channel
XLV, UNH, MRK, AMGN: ETF Inflow Alert
Tuesday, August 8, 2017, 10:49 AM — ETF Channel
Ligand (LGND) Q2 Earnings & Revenues Top, 2017 View Raised
Tuesday, August 8, 2017, 9:14 AM — Zacks
Radius (RDUS) Q2 Loss Wider than Expected on Higher Expenses
Friday, August 4, 2017, 1:43 PM — Zacks
Allergan (AGN) Q2 Earnings & Sales Top, Restasis Sales Down
Thursday, August 3, 2017, 8:50 AM — Zacks
Pfizer (PFE) Surpasses Q2 Earnings Estimates, Misses Sales
Tuesday, August 1, 2017, 8:11 AM — Zacks
3 ETFs to Watch Out for on Biotech Earnings
Monday, July 31, 2017, 10:26 PM — Zacks
Noteworthy ETF Outflows: XLV, AMGN, AET, ANTM
Monday, July 31, 2017, 10:50 AM — ETF Channel
Sanofi (SNY) Q2 Earnings In Line, Sales Lag,'17 View Raised
Monday, July 31, 2017, 8:41 AM — Zacks
See Which Of The Latest 13F Filers Holds Amgen
Thursday, July 27, 2017, 11:44 AM — Dividend Channel
Company News for July 27, 2017
Thursday, July 27, 2017, 8:44 AM — Zacks
Pharma Stocks to Watch for Earnings on Jul 28: ABBV, MRK
Thursday, July 27, 2017, 8:42 AM — Zacks
AMGN Named A Top Socially Responsible Dividend Stock
Thursday, July 27, 2017, 7:45 AM — ETF Channel
Noteworthy Tuesday Option Activity: AMGN, NEM, JPM
Tuesday, July 25, 2017, 1:38 PM — Stock Options Channel
Biogen (BIIB) Tops Q2 Earnings & Sales, Spinraza Sales Up
Tuesday, July 25, 2017, 12:37 PM — Zacks
Surprise in Store for Healthcare in Q2: Buy Top-Ranked ETFs
Monday, July 24, 2017, 8:11 AM — Zacks
Big Pharma Q2 Earnings Releases on Jul 25: LLY, BIIB, AMGN
Monday, July 24, 2017, 6:16 AM — Zacks
XLV, UNH, MRK, AMGN: Large Outflows Detected at ETF
Friday, July 21, 2017, 10:51 AM — ETF Channel
Ligand Signs Agreement with Amgen, Grants Rights to Captisol
Tuesday, July 18, 2017, 8:37 AM — Zacks
Novartis Tops Q2 Earnings, Sandoz Faces Pricing Pressure
Tuesday, July 18, 2017, 7:46 AM — Zacks
Why Did Radius Health (RDUS) Stock Plummet Today?
Monday, July 17, 2017, 10:28 AM — Zacks
Mylan's Biosimilar Herceptin Gets FDA Advisory Committee Nod
Monday, July 17, 2017, 9:00 AM — Zacks
Amgen (AMGN) Gets CRL for Osteoporosis Drug Evenity's BLA
Monday, July 17, 2017, 8:29 AM — Zacks
Notable Friday Option Activity: REGN, DDD, AMGN
Friday, July 14, 2017, 3:44 PM — Stock Options Channel
Can Novartis (NVS) Spring a Surprise This Earnings Season?
Friday, July 14, 2017, 6:18 AM — Zacks
Can ImmunoGen's Lead Pipeline Cancer Candidate Boost Growth?
Thursday, July 13, 2017, 2:38 PM — Zacks
Health Care Select Sector SPDR Fund Experiences Big Inflow
Thursday, July 13, 2017, 10:48 AM — ETF Channel
Amgen's Myeloma Drug Improves Overall Survival in Phase III
Thursday, July 13, 2017, 8:30 AM — Zacks
Amgen Gets FDA Nod to Broaden Leukemia Drug Blincyto's Label
Wednesday, July 12, 2017, 8:05 AM — Zacks
Are Medicines Company's Key Drugs Set for Growth in 2017?
Monday, July 10, 2017, 2:50 PM — Zacks
Novartis' Cosentyx Superior to Stelara in Psoriasis Study
Monday, July 10, 2017, 9:12 AM — Zacks
Merck Falls as FDA Puts Hold on 3 Keytruda Myeloma Studies
Thursday, July 6, 2017, 7:53 AM — Zacks
XLV, UNH, MRK, AMGN: Large Inflows Detected at ETF
Wednesday, July 5, 2017, 10:50 AM — ETF Channel
AMGN is categorized under the Healthcare sector; below are links to news for some other companies in the same sector:

GILD News
ALXN News
JNJ News
PFE News
BIIB News
XRAY News
OCR News
VPHM News
CYBX News
SKH News

RediNews invites those seeking web page financial content for any internet portal, especially any vertical portal specializing in the markets where there is a web page for business, web page for markets, web page finance, etc., to integrate our free web site content, our RSS news feeds. These RSS feeds are found throughout our website wherever news and custom stock content is found, by clicking the RSS icon for any news page (which will look like this): . This dynamic financial content is ideal for sites that already feature stock data content such as historical stock price information whether in the form of a historical stock price table or a web page chart image, to supplement the other custom stock market content displayed.

AMGN News | www.RediNews.com | Copyright © 2013 - 2018, All Rights Reserved

Nothing in www.RediNews.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.